MyAverix Finance
SHG · Healthcare
Zhejiang East Asia Pharmaceutical Co. Ltd. (605177)
Biotechnology
Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.43B, P/E ratio is 18.00, net margin is -26.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 605177
Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) — FAQ
What is Zhejiang East Asia Pharmaceutical Co. Ltd.'s market cap?
Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) has a reported market cap of $2.43B (data as of 2026-03-29).
What is 605177's P/E ratio?
The price-to-earnings (P/E) ratio for Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) is 18.00 (data as of 2026-03-29).
Does Zhejiang East Asia Pharmaceutical Co. Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Zhejiang East Asia Pharmaceutical Co. Ltd. (605177). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhejiang East Asia Pharmaceutical Co. Ltd. in?
Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 605177 listed on?
605177 is listed on SHG.
What is Zhejiang East Asia Pharmaceutical Co. Ltd.'s net margin?
Zhejiang East Asia Pharmaceutical Co. Ltd. (605177) reports a net margin of -26.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.